Android-25 Side Effects

Generic name: methyltestosterone

Medically reviewed by Drugs.com. Last updated on Oct 10, 2024.

Note: This document provides detailed information about Android-25.

Applies to methyltestosterone: oral capsules, oral tablets Side Effects associated with methyltestosterone. Some dosage forms listed on this page may not apply specifically to the brand name Android-25.

Applies to methyltestosterone: oral capsules, oral tablets.

Side effects include:

Males: Gynecomastia, frequent or persistent penile erections.

Females: Amenorrhea, other menstrual irregularities, inhibition of gonadotropin secretion, virilization (e.g., deepening of the voice, clitoral enlargement).

For healthcare professionals

Applies to methyltestosterone: compounding powder, oral capsule, oral tablet.

General adverse events

The more commonly reported adverse effects of androgen therapy in males is gynecomastia and excessive frequency and duration of penile erections; in women, virilization including voice deepening and clitoral enlargement.^[Ref]

Cardiovascular

• Frequency not reported: Edema with or without congestive heart failure, myocardial infarction, stroke
• Postmarketing reports: venous thromboembolic events, including deep vein thrombosis (DVT)^[Ref]

Endocrine

• Frequency not reported: Gynecomastia, virilization (women), hirsutism^[Ref]

Hepatic

• Rare (less than 0.1%): Peliosis hepatic
• Frequency not reported: Cholestatic jaundice, altered liver function^[Ref]

Genitourinary

• Frequency not reported: Amenorrhea, menstrual irregularities, excessive frequency and duration of penile erections, oligospermia, increased or decreased libido^[Ref]

Metabolic

• Frequency not reported: Retention of sodium, chloride, water, potassium, calcium and inorganic phosphates, increased serum cholesterol, hypercalcemia^[Ref]

Dermatologic

• Frequency not reported: Male pattern baldness, acne^[Ref]

Gastrointestinal

• Frequency not reported: Nausea, vomiting^[Ref]

Musculoskeletal

• Frequency not reported: acceleration of bone maturation without producing compensatory gain in linear growth resulting in compromised adult stature^[Ref]

Hematologic

• Frequency not reported: Suppression of clotting factors II, V, VII, and X; bleeding (in patients on concomitant anticoagulant therapy and polycythemia)^[Ref]

Hypersensitivity

• Very rare (less than 0.01%): Anaphylactoid reactions^[Ref]

Nervous system

• Frequency not reported: Headache, generalized paresthesia^[Ref]

Oncologic

• Rare (less than 0.1%): Hepatocellular neoplasms^[Ref]

Respiratory

• Postmarketing reports: venous thromboembolic events, including pulmonary embolism^[Ref]

Psychiatric

• Frequency not reported: Steroid abuse, anxiety, depression

See also:

Further information

Android-25 side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.

Medical Disclaimer